Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA290034
Max Phase: Preclinical
Molecular Formula: C44H55N7O9S
Molecular Weight: 858.03
Molecule Type: Small molecule
Associated Items:
ID: ALA290034
Max Phase: Preclinical
Molecular Formula: C44H55N7O9S
Molecular Weight: 858.03
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C(=O)[C@H](CCCCNC(=O)/C=C/c1cccs1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)[C@@H](CC(=O)O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C44H55N7O9S/c1-44(2,3)60-43(59)49-34(25-29-27-47-32-18-10-9-17-31(29)32)40(56)48-33(19-11-12-22-46-37(52)21-20-30-16-13-23-61-30)41(57)51(5)36(26-38(53)54)42(58)50(4)35(39(45)55)24-28-14-7-6-8-15-28/h6-10,13-18,20-21,23,27,33-36,47H,11-12,19,22,24-26H2,1-5H3,(H2,45,55)(H,46,52)(H,48,56)(H,49,59)(H,53,54)/b21-20+/t33-,34?,35-,36-/m0/s1
Standard InChI Key: YRULVPAVSSLIEL-MMUNOSDDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 858.03 | Molecular Weight (Monoisotopic): 857.3782 | AlogP: 4.01 | #Rotatable Bonds: 21 |
Polar Surface Area: 233.33 | Molecular Species: ACID | HBA: 9 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.14 | CX Basic pKa: | CX LogP: 3.67 | CX LogD: 0.60 |
Aromatic Rings: 4 | Heavy Atoms: 61 | QED Weighted: 0.05 | Np Likeness Score: -0.31 |
1. Bennett MJ, Nikkel AL, Bianchi BR, Miller TR, Bednarz L, Witte DG, Stashko M, Wang SS, Gore PA, Asin KE.. (1994) CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue., 37 (11): [PMID:8201591] [10.1021/jm00037a006] |
Source(1):